Sandbox: Kaposi 2

Revision as of 19:01, 21 January 2016 by Haytham Allaham (talk | contribs)
Jump to navigation Jump to search
  • Local/regional therapy recommended for the management of Kaposi's sarcoma patients may include:
  • Surgical excision
  • Cryotherapy
  • Sclerotherapy
  • Intralesional vinca-alkaloids, bleomycin, and interferon-alpha
  • Topical 0.1% alitretinoin
  • Imiquimod cream
  • Radiotherapy
  • Laser therapy
  • HAART therapy regimens recommended for the management of Kaposi's sarcoma patients may include:
  • Non nucleoside reverse transcriptase (NNRT)-based therapy
  • Protease Inhibitor (PI)-based therapy
  • Chemotherapy regimens recommended for the management of Kaposi's sarcoma patients may include:
  • Liposomal anthracyclins
  • Paclitaxel
  • Oral etoposide
  • Doxorubicin AND bleomycin AND vincristine
  • Doxorubicin AND bleomycin AND vinblastine
  • Immune modulators recommended for the management of Kaposi's sarcoma patients may include:
  • Interferon-alpha
  • Targeted therapies recommended for the management of Kaposi's sarcoma patients may include:
  • Antiherpes therapy
  • Angiogenic inhibitors (e.g., thalidomide)
  • VEGF inhibitors
  • Tyrosine kinase inhibitors
  • Matrix metalloproteinases
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:_Kaposi_2&oldid=1204839"